Expanding on Current Definitions of Hematologic Improvement in MDS, CMML and AML: Landmark Analyses of 1301 Patients Treated with Azacitidine in the Austrian Registry of Hypomethylating Agents By the AGMT-Study Group: American Society of Hematology, 61th Annual Meeting, scientific session

Lisa Pleyer, Michael Pfeilstocker, Reinhard Stauder, Sonja Heibl, Heinz Sill, Michael Girschikofsky, Margarete Stampfl-Mattersberger, Christoph Tinchon, Andreas Petzer, Clemens A. Schmitt, Sonia Vallet, Inga Mandac, Klaus Geissler, Wolfgang R. Sperr, Michael Leisch, Alexander Egle, Thomas Melchardt, Julia Fusinato, Gudrun Piringer, Armin ZebischSigrid Machherndl-Spandl, Dominik Wolf, Felix Keil, Richard Greil

Publikation: Beitrag in Fachzeitschrift (peer-reviewed)Konferenzbeitrag in Fachzeitschrift

Fingerprint

Untersuchen Sie die Forschungsthemen von „Expanding on Current Definitions of Hematologic Improvement in MDS, CMML and AML: Landmark Analyses of 1301 Patients Treated with Azacitidine in the Austrian Registry of Hypomethylating Agents By the AGMT-Study Group: American Society of Hematology, 61th Annual Meeting, scientific session“. Zusammen bilden sie einen einzigartigen Fingerprint.

Medicine and Dentistry

Nursing and Health Professions